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Background: A great deal of attention has been directed at the necessity and potential for deleterious outcomes as a result
of radiation exposure during diagnostic evaluations and interventional procedures. We embarked on this study in an
attempt to accurately determine the amount of radiation exposure given to patients undergoing complex endovascular
aortic repair. These measured doses were then correlated with radiation dose estimates provided by the imaging
equipment manufacturers that are typically used for documentation and analysis of radiation-induced risk.
Methods: Consecutive patients undergoing endovascular thoracoabdominal aneurysm (eTAAA) repair were prospectively
studied with respect to radiation dose. Indirect parameters as cumulative air kerma (CAK), kerma area product (KAP),
and fluoroscopy time (FT) were recorded concurrently with direct measurements of dose (peak skin dose [PSD]) and
radiation exposure patterns using radiochromatic film placed in the back of the patient during the procedure.
Simultaneously, operator exposure was determined using high-sensitivity electronic dosimeters. Correlation between the
indirect and direct parameters was calculated. The observed radiation exposure pattern was reproduced in phantoms with
over 200 dosimeters located in mock organs, and effective dose has been calculated in an in vitro study. Scatter plots were
used to evaluate the relationship between continuous variables and Pearson coefficients.
Results: eTAAA repair was performed in 54 patients over 5months, of which 47 had the repair limited to the thoracoabdomi-
nal segment. Clinical follow-upwas complete in 98%of the patients.No patients had evidence of radiation-induced skin injury.
CAK exceeded 15Gy in 3 patients (the Joint Commission on Accreditation ofHealthcare Organizations [JCAHO] threshold
for sentinel events); however, the directmeasurementswerewell below15Gy in all patients. PSDwasmeasured by quantifying
the exposure of the radiochromatic film. PSD correlated weakly with FT but better with CAK and KAP (r 0.55, 0.80, and
0.76, respectively). The following formula provides the best estimate of actual PSD  0.677  0.257 CAK. The average
effective dose was 119.68 mSv (for type II or III eTAAA) and 76.46 mSv (type IV eTAAA). The operator effective dose
averaged 0.17 mSv/case and correlated best with the KAP (r  0.82, P < .0001).
Conclusion: FT cannot be used to estimate PSD, and CAK and KAP represent poor surrogate markers for JCAHO-defined
sentinel events. Evenwhen directly measured PSDswere used, there was a poor correlation with clinical event (no skin injuries
with an average PSD >2 Gy). The effective radiation dose of an eTAAA is equivalent to two preoperative computed
tomography scans. The maximal operator exposure is 50 mSv/year, thus, a single operator could perform up to 294 eTAAA
procedures annually before reaching the recommended maximum operator dose. (J Vasc Surg 2011;53:885-94.)
h
a
t
t
s
w
i
T
0Over the last 40 years, there has been a proliferation of
fluoroscopically-guided minimally invasive procedures. Tech-
nological advances relating to imaging equipment coupled
with greater procedural complexity has resulted in the poten-
tial for substantial radiation exposure risks for both patients
and operators.1 Consequently, the quantification of radiation
exposure and assessment of any radiation effects are now
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deavily scrutinized by themedical community, general public,
nd regulatory agencies.2 Detrimental effects from exposure
o radiation can be classified as either deterministic or stochas-
ic. Deterministic effects are predictable dose-related re-
ponses and, therefore, have a specific dose threshold below
hich the effect does not occur, and above which the severity
ncreases, usually in proportion to the dose. Stochastic effects,
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April 2011886 Panuccio et alin contrast, are probabilistic in nature, the primary effect being
carcinogenesis. Severity has no relationship to dose and no
absolute threshold can be defined; however, the incidence
increases with the dose.
The potential for unintended injury or illness underscores
the importance of attempting to quantify the risk to operators
and patients; the techniques used to quantify exposure dose
remain imprecise. The two principal methods used to
report approximate radiation dose are fluoroscopy time
(FT; in minutes) and cumulative air kerma (CAK; in Gy),
yet such indirect parameters are global estimates of dose
and have the potential for considerable error (Table I).
Factors such as image magnification, tube angle, patient
position, body habitus, and other variables challenge the
accuracy of the automated exposure methods and re-
ports. Studies correlating direct measurements of expo-
sure using the commonly supplied automated estimates
of exposure for vascular procedures are lacking. In an
attempt to further define radiation risk to patients and
operators during endovascular procedures, we chose to
evaluate one of the most complex endovascular proce-
dures, endovascular thoracoabdominal aneurysm repair
(eTAAA) using branched endografts, by directly measur-
Table I. Summary of the radiation quantity with comparis
ideal parameter
Indirecta
FT CAK KA
Description Amount of time
the X-ray
beam is
activated.
The sum of initial
kinetic energies
of all charged
particles liberated
by X-rays per
unit mass of air.b
Total X-r
in the
produc
kerma
beam a
Units of
measurement
Minutes Gy Gy  cm
Limits Does not take
beam quality
or output rate
into account.
Does not account
for different
beam
projections. Also
does not inform
how much area
was exposed.
Does not
for diff
project
Beam
cumul
dose u
Availability Provided by all
fluoroscopy
units.
Provided by most
fluoroscopy
units.
Provided
fluoros
units.
Accounts for
acquisitions
No Yes Yes
CAK, Cumulative air kerma; ED, effective dose; FT, fluoroscopy time; Gy,
aDirect parameters provide data that directly relate to deterministic or stoch
bGenerally measured at 15 cm toward a focal spot from the isocenter of a C-
skin dose and eventual sentinel with a threshold of 15 Gy.ing radiation exposure. Accurate quantification of radia- sion dose allows correlation to the automated dose re-
orting systems with the measured dose to better predict
he deterministic effects while also providing informa-
ion on exposure patterns to allow for the stochastic risk
stimate to be calculated.
ETHODS
Between May and December 2009, consecutive TAAA
atients treated with custom-designed endovascular devices
ere prospectively enrolled in this study. All procedures were
ntended to be single-stage, complete TAAA repair. Informed
onsent was obtained from all patients and the study was
pproved by the Institutional Review Board of the Cleveland
linic Foundation. The procedures were performed by expe-
ienced operators in conjunction with an assistant clinical
ellow and a scrub nurse. Three interventional surgeons (au-
hors RKG, ME, and TM) were involved, and the specifics
elating to the procedure and technical details have been
reviously described.3-5 Skin changeswere assessed daily post-
peratively until discharge and then during a clinical follow-
p, which occurred between 20 and 45 days.
Indirect estimates of dose. All procedures were per-
ormed under fluoroscopic guidance using a fixed imaging
etween the indirect parameter normally available and the
Directa
PSD Isodose ED
x
,
Highest amount
of energy
locally
deposited per
unit mass in a
defined skin
area.
Amount of area
or volume that
reach a defined
threshold.
An attributed whole-
body dose that
produces the same
stochastic risk as
an absorbed dose
to a limited
portion of the
body.
Gy Area, often cm2 Sv
unt
nd
wn.
No real time
assessment.
No real time
assessment.
Impossible in vivo
and no real-time
assessment.
ost Labor intensive –
must use
Gafchromic
film and either
a film
densitometer
or analysis
software.
Labor intensive –
must use
Gafchromic
film and
analysis
software.
Not available, must
be estimated.
Yes Yes Yes
KAP, kerma area product; PSD, peak skin dose; Sv, Sievert.
ffects. Indirect parameters do not.
pe fluoroscope (interventional reference point). This is used to monitor theon b
P
ay flu
beam
t of
and
rea.
2
acco
erent
ions.
size a
ative
nkno
by m
copy
Gray;
astic eystem (Artis Zeego or Artis TA, Siemens, Erlangen, Ger-
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Volume 53, Number 4 Panuccio et al 887many) with the image generator primarily situated under-
neath the patient (posterior-anterior projections). Indirect
estimates of exposure included the FT and the kerma area
product (KAP), sometimes referred to as the dose area prod-
uct (DAP), andCAK.Additional informationwas available for
digital subtraction acquisition runs (Table II). Although the
default settings could be changed at any time by the operator,
the fluoroscopy pulse rate was set at 7.5 pulses per second and
the acquisition frame rate was set at three frames per second.
Direct measurement of skin dose. Multiple pieces of
Gafchromic film (International Specialty Products, Wayne,
NJ) were placed beneath the patient facing the X-ray tube to
record the total radiation dose distribution. Given the large
film size and wide energy response, this method is considered
to be the most reliable way to record the entrance radiation
dose distribution during interventional procedures.6,7 This
resulted in total coverage of the thoracoabdominal region and
ability to detect any exposure with the exception of a perfectly
lateral (90°) C-arm angle. The X-ray film was removed post-
procedure and allowed to stabilize for at least 48 hours before
analysis.6 A calibration strip ofGafchromic filmwas created for
each lot of film used in a range of absorbed doses between 0.5
Gray (Gy) and 12.5 Gy using methods recommended by the
manufacturer. Each patient’s X-ray film along with the asso-
ciated calibration stripwas scannedusing anEpsonExpression
10000XL (Epson, San Jose, Calif) at 48-bit depth and 50-dpi
resolution. The Radiological Imaging Technology software
package (Radiological Imagining Technology,Denver, Colo)
was used to perform radiation dose mapping. For each set of
patient films, a peak skin dose (PSD), three-dimensional (3D)
dose profile, and isodose curves (for the 95% PSD) were
computed, while the 2 Gy and 0.05 Gy isodose areas were
calculated (Fig 1). In an effort to account for the effect of
patient size and radiation field on skin dose distribution, the
ratio betweenPSDand theCAKwas computed anddefined as
the dose index.8 A ratio close to one is indicative of a focused
region of exposurewith a potentially high dose, whereas when
the ratio approaches zero, the implication is that the exposure
is diffuse or distributed over a considerable body surface area.
Direct measurements of specific organ dose and
estimate of effective dose. To calculate effective doses,
Table II. Parameters available and automatically
collected from the radiographic system
Acquisitions
Cranio-caudal and lateral angulations
Field of view
X-ray tube current (mA)
X-ray tube potential (kVp)
Additional filtration
Total number of frames
Frame rate
Kerma area product
Cumulative air kerma
Combined fluoroscopy and acquisition summary
Fluoroscopy time
Kerma area product
Cumulative air kermaspecific organ dose information is necessary. Once known, che organ doses are multiplied by a tissue-weighting factor
nd summed to establish the effective dose. Estimates of
he organ doses were obtained using a Rando-Alderson
nthropomorphic tissue equivalent phantom (Rando-Al-
erson Laboratory, Salem, NY). The phantom (without
xtremities) consisted of 34 individual sections ranging
rom the head through the pelvis (overall height of 163 cm,
eight of 53 kg, density of 0.985 g/cm, and effective
tomic number of 7.3). Lithium fluoride thermolumines-
ence dosimeters (TLD) were inserted into the phantom
aterial at specific locations to measure relative organ dose
n a manner consistent with the literature standards.9-11
he mean patterns of exposure to the patients were deter-
ined from the recorded projections data (Table II) by the
maging system along with the average KAP delivered in
ach projection. These projections and KAP measurements
ere then reproduced on the phantommodels loaded with
rgan-specific TLDs (separate phantoms were used for the
wo patterns of exposure—type II and III eTAAA repair vs
ype IV eTAAA repair). The TLDs were supplied and
valuated by a third party, NAVLAP, which is an accredited
osimetry vendor (Mirion Technologies, San Ramon,
alif). Organ doses were determined from the TLDs based
n methodology established by Huda and Sandison.9 The
rgan doses were then used to compute an effective dose
or each pattern of exposure using tissue weighting factors
wT) established by the International Commission on Ra-
iological Protection (ICRP) in Publication 103.12 To
rovide an effective dose reference value, we evaluated each
atient’s exposure during a preoperative chest, abdomen,
nd pelvis computed tomography (CT) scan. To calculate
he effective dose (ED; measured in mSv), the dose length
roduct (measured in mGy●cm and provided by the imag-
ng system in a patient study-specific manner) was multi-
lied by the specific conversion factors (coefficient  
.017 mSv mGy1 cm1 for CT scans).13
Operator exposure. All the operators wore radiation
rotective glasses and personal custom-made aprons with a
hickness of 0.5-mm lead equivalent. However, supplemental
hielding methods differed slightly between the two types of
maging system rooms (Fig 2). Measurements of operator
ose were carried out using electronic personal dosimeters
Unfors EDD-30; Unfors Instruments AB, Gothenburg,
weden). The dosimeters were positioned external to the
linician’s lead apron at the level of the neck. The sensor has a
pherical response that is capable of measuring the dose inde-
endent to the incident angle of radiation. The range of
etectable accumulated dose is 10 nSv to 9999 Sv, and a
rigger level dose was not set. Compared with the standard
adges for the monthly operator surveillance, this system is
ntended to be reliable for the assessment of exposure during
single procedure (deep dose equivalent [DDE]). The oper-
tor ED was calculated according to the Webster methodol-
gy multiplying the DDE times 0.3.14
Data collection and statistical analysis. Clinical data,
ntraoperative details, and exposure parameters from the
reoperative CT scan were prospectively recorded in a
omputerized database (ORACLE; Oracle Corporation,
JOURNAL OF VASCULAR SURGERY
April 2011888 Panuccio et alFig 1. Skin dose distribution in patients treated with an endovascular branched graft for a type IV thoracoabdominal
aortic aneurysm (TAAA) is depicted here. The body habitus in relation to the Gafchromic film is displayed in (A). The
film is then automatically analyzed to construct a plot of the peak skin dose (PSD) and the isodose areas (B) where it
can be displayed as a 3-dimensional (3D) histogram (C). The blue, orange, and red regions on (B) correspond to 50%,
75%, and 95% isodose areas, respectively.
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Volume 53, Number 4 Panuccio et al 889Redwood Shores, Calif). Mean values and SDs as ranges
were calculated for all the variables. Scatter plots were
created to evaluate the relationship shape between contin-
uous variables and the corresponding Pearson correlation
coefficients (r) and t test were calculated. P value .05 was
considered statistically significant.
RESULTS
The study included 47 patients who all underwent
eTAAA repair. There were seven additional patients treated
for TAAAs during the time period, all of which included at
least one hypogastric branch in addition to the eTAAA
repair and were thus excluded from analysis. Details about
the patient population and procedures are depicted in
Table III. Clinical and imaging follow-up compliance
through the study period was 98%. The indirect radiation
parameters provided by the imaging system software are
depicted in Table III. As expected, type II and III eTAAA
repair resulted in greater amounts of fluoroscopy time and
higher estimates of exposure in comparison to type IV
TAAA (FT P  .001; CAK P  .009; KAP P  .032,).
Similarly larger patients (major body mass index) had a
higher estimated dose (CAK and KAP, r  0.3, P  .038
and r  0.3, P  .031, respectively) but no increase in the
FT (r  0.1, P  .489).
Direct measurement of the skin dose. PSD was de-
Fig 2. Maximal protection for the operators is emphasized in the
operating room environment. These images depict the two mobile
transparent lead shields (Mavig Inc, Munich, Germany) that are
placed between the operator and flat panel detector (black arrows).
Additionally, a lead skirt is mounted on either side of the table (BT
Medical Company, Inc, Bridgeport, Pa) that is intended to reside
between the image generator and operators (white arrow). A
shoulder attached to the under table skirt further helps to prevent
scatter (red arrow).termined by analyzing the Gafchromic film. Each field oincluding 95% of the exposure in continuity with the
egion of PSD) of exposure was assessed separately using
he digitized scanned image. The mean PSD was 2.5 Gy
nd the average size of the area surrounding 95% of the
SD area was 4 cm2. The PSD center varied from patient to
atient and general patterns are depicted in Fig 3. A 2-Gy
hreshold is commonly used to estimate a “high risk of skin
amage,” and 51% of our patients exceeded the “high risk”
-Gy threshold. Higher PSDs were correlated with the
xtent of the aneurysm (type II and III vs type IV; P 
035) and larger bodymass index (r 0.49, P .001). The
ose index was 0.37, perhaps explaining the absence of any
linical evidence of radiation-induced skin damage in any of
able III. Demographic data, indirect and direct
adiation exposure parameter related with the procedures
ge 74.7 (7.6)
ale 83%
SA 3 68%
SA 4 32%
n %
AAA
Type II 6 12.8
Type III 12 25.5
Type IV 29 61.7
ranch vessels per procedure
2 8 17
3 17 36
4 22 47
Median IQR
NDIRECT
Contrast dose (mL) 137 94.2
Operation time (min) 312 177.25
FT (min) 82.7 80.5
CAK (Gy) 6.3 5.0
KAP (Gy cm2) 696.6 520
DIRECT
PSD (Gy) 2.0 2.3
Dose index 0.38 0.18
sodose area (cm2)
95% 3.1 4.2
2 Gy 95.0 118.0
0.05 Gy 1262.5 721.5
Comparison based on the aneurysm type
P value
TAAA type II & III (n  18) IV (n  29)
Mean (SD) Mean (SD)
AK (Gy) 9.6 (5.7) 6.1 (3.1) .009
AP (Gy cm2) 1005.7 (627.8) 642.5 (311.6) .032
T (min) 140.7 (64.4) 81.9 (45.8) .001
SD (Gy) 3.2 (1.6) 2.2 (1.3) .035
SA, American Surgical Association; CAK, cumulative air kerma; FT,
uoroscopy time; Gy, Gray; IQR, interquartile range; KAP, kerma area
roduct; PSD, peak skin dose; TAAA, thoracoabdominal aortic aneurysm.
he area interested by highest radiation (isodose area at 95% of the PSD) is
sually very small, results of the small overlapping of different beam projec-
ion, in the same time, total area exposed is wide as shown by the isodose area
t 0.05 Gy and by the dose index. The radiation exposure comparison was
ased on the aneurysm type, it shows that the extension of the treatment is
ssociated with an increase of radiation exposure for the patient.ur patients.
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ments. All indirect parameters of radiation exposure (FT,
CAK, and KAP) correlated with direct measurements of the
PSD (FT: r  0.55, P  .001; CAK: r  0.80, P  .0001;
and KAP: r  0.76; P  .0001; Fig 4). Based on the
correlation analysis, it was possible to provide a better
estimation of the measured PSD using the indirect dose
estimates (except for FT) provided by the imaging system
by applying the formulas depicted in Fig 4.
Stochastic effects. Organ and tissue doses measured
in the anthropomorphic phantom using the average expo-
sure conditions for the patients in this study are shown in
Table IV (online only) and Fig 5. Doses were then calcu-
lated for each patient based on their specific exposures and
patterns of exposure using the ratio of the DAP and ED in
the phantom; the results are depicted in Table IV (online
only). The average effective doses were estimated to be
103.1 mSv (range, 24.5-218.1 mSv) and 127.6 mSv
(range, 33.2-373.8), respectively, for TAAA type 4 and
types 2 and 3. The associated conversion factors were 0.160
mSv · mGy1 · cm2 (TAAA type 4) and 0.127
mSv · mGy1 · cm2 (TAAA types 2 and 3). As a point of
reference, the average effective dose for a two- or three-
phase CT scan in this patient population was 34mSv and 60
mSv, respectively.
Operator exposure. The DDE was 0.56 mSv (range,
0.22-2.70 mSv), and all indirect parameters correlated with
measured operator dose (KAP: r  0.82, P  .0001; Fig 6;
CAK: r 0.75,P .001; FT: r 0.69,P .001).Using the
Webster’s method, the average operator effective dose was
estimated to be 0.17 mSv/procedure. Comparing this value
Fig 3. Localization of the peak skin dose (PSD). In most of the
cases, the PSD was focused on the central part of the back and
attributed to work related to the renal branches. High PSD in the
lateral regions occurred when challenges with the celiac or superior
mesenteric artery (SMA) were encounteredto the limit for occupational exposure suggested by the ICRP s100 mSv in 5 years and maximal 50 mSv/year), using our
alculated operator dose estimates, the maximum number of
rocedures each operator can perform annually is 294.15
ISCUSSION
The Euratom 97/43 directive introduced the obliga-
ion to carry out a dosimetric evaluation of radiation expo-
ig 4. Scatter plot with trend line and formulas demonstrating
he strong correlation between the direct parameter versus cumu-
ative air kerma (CAK) and dose area product (DAP; respectively,
and B). C, Scatter plot showing the weak correlation between
he direct parameter and the fluoroscopy time (FT).Gy,Gray; PSD,
eak skin dose; KAP, kerma area product.ure for “high-dose practices,” including interventional
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Volume 53, Number 4 Panuccio et al 891radiology procedures.16 The US Food and Drug Adminis-
tration requires the identification and registration of all
procedures exposing patients to a maximum skin dose of
more than 1 Gy over a period of 6 months (thus, procedure
plus perioperative scans for eTAAA and reintervention or
staged procedures).17
In addition, the Joint Commission on Accreditation of
Healthcare Organizations (JCAHO) includes radiation
Fig 5. To establish a pattern in an effort to simulate th
kerma area product (KAP) and the magnification data fr
exposure intended to assess effective dose during the end
The average KAP used in each sector is reported as a perc
depicted the pattern for types 2 and 3 TAAAs and on th
Fig 6. Scatter plot with trend line demonstrating the correlation
between the operator exposure detected with a dosimeter worn
externally to the apron and the kerma area product (KAP). Gy,
Gray.events that are reviewable under the “Sentinel Event Pol- acy” such as high-dose fluoroscopy with cumulative dose
15 Gy to a single field.18 However, the method by which
ose is established is not defined in the JCAHO or Food
nd Drug Administration requirements. Furthermore,
here exists no single indirect dosimetry quantification
ethod that is capable of accurately providing unequivocal
nformation regarding the induction of deterministic radi-
tion. FT, although the simplest parameter measure, is the
east accurate assessment of dose. In our analyses, all three
ndirect parameters overestimated the directly measured
SD. Furthermore, given that there were no clinical effects
f relatively high PSDs in any patient, these “high-risk skin
njury” guidelines did not accurately apply to this patient
opulation. These observations cause one to question the
pplicability of such guidelines for peripheral vascular (aor-
ic) interventions where the exposure is distributed over a
elatively greater area than coronary or neurointerventional
rocedures, perhaps best exemplified by the low dose index
n comparison to other procedures.19
Film-based methods for determination of PSD have
ong been considered the most reliable method for measur-
ng skin dose. However, such methods are labor intensive
nd the results are not available in real time, thus are usually
elegated to investigative reports such as this. We found a
elatively strong relationship between PSD and both CAK
ndKAPmaking it possible to use these indirect parameters
cedure, projection patterns were determined using the
ch acquisition. These data were replicated for phantom
ular thoracoabdominal aneurysm repair (eTAAA) repair.
e of the average KAP per procedure. (On the left side is
t for type 4.)e pro
om ea
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entags real time indicators, which increase in accuracy using the
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and of 607 Gy-cm2 for KAP, corresponds to 2 Gy of
directly measured PSD. FT, on the other hand, does not
seem to be a reasonable assessment of the dose assessment.
In our study, over half of the patients (51%) had a measured
PSD in excess of 2 Gy, yet skin changes were not observed
in any of our patients. However, it is obviously prudent to
minimize the PSD in any one region. This can be accom-
plished by optimization of the beam collimation, reduction
of the milliampere (mA), fewer fluoroscopy pulses, and
acquisition images coupled with frequent changes in the
pattern of the radiation field by altering the tube angle.
New methods of estimating patient dose that incorporate
maps of the patient body surface, allowing the operator to
redirect the beam to “cold” areas of exposure during pro-
longed procedures are under investigation.
The KAP (Gy-cm2) is a quantity, which historically has
been used to correlate with stochastic effects of radiation
exposure. Fundamentally, the KAP is a goodmarker for the
number of X-ray interactions with the patient. The effects
of doubling either the dose or irradiated area will double
the number of interactions, and thus will theoretically
double the risk of a stochastic effect. However, the KAP
value alone does not take into account which portion of the
body is exposed, and given that some organs have a greater
risk of carcinogenesis (such as the breast, thyroid, and
liver), the stochastic risk must be calculated using organ-
specific information. To quantify organ-specific risk simu-
lations, use of phantom models is required. However, the
application of phantom model data requires fundamental
assumptions in addition to a reproducible pattern of radia-
tion exposure. Our data depicted two different patterns of
exposure that were most closely related to the proximal
extent of the aortic disease. Therefore, two separate phan-
tom models were used to assess the organ-specific dose for
each type of repair group. Factors that cannot be accounted
for include any tissue healing that may occur, and the time
interval between radiation exposures. The calculated effec-
tive dose must then be compared to that of other proce-
dures, and viewed in the context of the clinical necessity of
the procedure or imaging study. It is hypothesized that 1 Sv
of exposure will result in a 4% increased risk of a fatal cancer.
If a patient were to undergo a single preoperative (two-
phase) CT scan, followed by an eTAAA repair for a type IV
TAAA, and two (three-phase) follow-up CT scans over a
1-year period, he or she would receive an average effective
dose of 200 mSv. Again, this assessment does not account
for any tissue healing that occurs between exposures which
is not well understood.20 Therefore, the 1 Sv exposure
estimate is cumulative to a certain extent but less likely
simply additive as the gap between exposure incidents
increases. The estimate that the effective dose of eTAAA
repair is equivalent to two three-phase CT scans allows for
the risk to be viewed in the context of everyday procedures.
Ironically, it seems relatively simple to require a patient to
undergo a endograft follow-up study, but it is much more
complicated to expose him or her to the radiation associ-
ated with an eTAAA repair. Clearly, efforts must bemade to recrease procedural doses, yet the bulk of exposure (over
ime) for patients undergoing endovascular aneurysm re-
air resides within the multiple CT scans used to assess
neurysms either preoperatively or postoperatively. Atten-
ion must be directed at the true need for such follow-up
tudies, and the minimization of the radiation dose during
ach follow-up examination. We have devoted efforts into
eans of decreasing the radiation exposure for each fol-
ow-upCT scan using specific CT imaging equipment (dual
nergy source data)21 and newer technologies are now
vailable that further decrease the dose by a factor of up to
0 with respect to conventional CT scanners. However, no
linical data have been generated documenting dose reduc-
ion in the setting of preserved image quality. Thus, there
xists a balance between the desire for dose reduction, the
reservation of image quality, and the perception and inter-
retation that the physician has with regard to the imaging.
Operator dose is also a critical factor that requires
nalysis. Interventionalists are required to wear film badges,
hich undergo monthly analysis at our institution. Should
n operator exceed 30% of the recommended ICRP limit
nnually, he or she is required to take a “refresher” exami-
ation relating to the use of radiation equipment. Operator
xposure is partially related to the complexity of the proce-
ure, but it is tempered by the appropriate use of specific
hielding. All operators are required to wear the standard
ead aprons (typically two-piece systems inclusive of a vest
nd skirt) in addition to thyroid collars. Additional protec-
ion measures at our institution include lead skirts attached
o the tables in all of our endovascular suites, and two types
f mobile shielding (ceiling mounted and above the lead
kirts). We would strongly discourage performing overly
omplex procedures using portable C-arm imaging sys-
ems, where a potential lower-image quality might be cou-
led with fewer shielding options, thus there may be un-
ecessary radiation exposure. However, the proper
ositioning of all of the shielding are operator dependent,
hus designs (even with non-fixed imaging systems) could
e implemented to accommodate such systems. The dis-
ance of the operator from the radiation source also plays a
ritical role in the reduction of exposure, and attention to
uch details during acquisitions is critical. The average
perator exposure was 0.17 mSv/procedure, resulting in a
aximum average of 294 eTAAA repairs annually.22 This
ould be a very large number of such procedures, yet we
ust remain cognizant of the cumulative effect of such
rocedures over several years.
The application of these data to other complex endo-
ascular procedures may not be reliably performed. For
xample, lower extremity procedures may involve some of
he same limitations for PSD. However, the intensity of the
eam (mA) is markedly reduced given the lesser amount of
issue penetration required for image clarity, and the ab-
ence of organs at high risk for carcinogenesis may lessen
he significance of a calculated effective dose. In contrast,
ardiac-based procedures may result in a higher risk of
arcinogenesis given the proximity of the breasts and thy-
oid to the beam focus. Thus, as patterns of exposure are
11
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carried out.
Several weaknesses exist within this analysis. A contin-
uous learning curve existed for individuals performing
eTAAA. Greater levels of experience resulted in less radia-
tion exposure ranging with a mean exposure dose of 5.4 Gy
for the most experienced operator to 7.7 Gy for others.
Furthermore, the mere effect of running a study to assess
radiation dose triggers awareness in the operators that may
affect their patterns of imaging applications. Finally, the
number of patients and phantoms used in this study were
limited, thus, the statistically derived calculations were not
necessarily powered to supply the required information.
These data provide useful information regarding the
measured radiation for eTAAA repair. There was a lack of
correlation between the industry-supplied means of dose
estimate with the directly measured dosing regimens used
in this study. These differences had implications with re-
gard to the required reporting of “high-dose” events to
regulatory agencies. Although conversion factors or formu-
las allow estimates to move close to the actual measured
dose, they are procedure (pattern)-specific. The dose for
these complex procedures is significant, but seems to pale in
comparison to the potential for several remote CT scans
that are routinely obtained during the follow-up of unop-
erated-on aneurysms of patients and the follow-up after
open or endovascular repair. Despite the fact that the
measured PSD remained substantial for this procedure, no
skin changes were observed. Formulas capable of estimat-
ing the PSD using the indirect parameters available real
time from the imaging equipment were developed and
correlate well with the direct measurements of PSD, but
again, given the absence of clinical evidence of radiation
damage, may have limited applicability. The effective dose
of eTAAA repair is roughly equivalent to two standard
chest, abdomen, and pelvis CT scans. The operator dose is
somewhat variable, but roughly 300 of these procedures
can be performed annually before reaching the recom-
mended exposure limits for interventionalists. New meth-
ods of reporting PSDs and effective doses are under devel-
opment and will allow operators to better visualize the areas
of exposure and thus mitigate risks.
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Dr Stephan Haulon, MD (Lillie Cedex, France). I noticed
that you used the fusion-imaging technique during the procedures
performed at the Cleveland Clinic, and you mentioned that maybe
it lowered the fluoroscopy time. I wonder if your conclusions are
applicable to other centers.
Dr Panuccio. Although we used fusion-imaging techniques
on most of the procedures (in which the preoperative CT scan is
registered with the fluoroscopic image to provide road marks of
branching aortic vessels), the pattern of exposure did not differ
significantly from cases in which fusion imaging was not available.
There is a benefit to fusion imaging in that the procedure may be
faster given that the general location of all the vessels is known, but
a cost in terms of radiation exposure because an intraoperative
Dyna CT scan must be performed. We think that these issues
balance out and there is not likely a significant difference in
exposure with or without fusion. Given the relatively linear rela-
tionship between the estimated and calculated exposure over small
changes in dose, the formulas provided should be accurate in either
situation.
Linda Harris, MD (Buffalo, NY). Did you measure the
radiation under the lead as is done for women who are pregnant?
Dr Panuccio.We measured the exposure external to the lead
worn by clinicians to provide a more accurate dose estimate. The
most accurate sensor available was chosen, and this seemed to be
sensitive enough to detect small changes in operator exposure
based on individual procedures, whereas such a practice would not
be possible inside the lead protection.
DrMarcMitchell (Jackson, Miss). I think this is a big issue for
vascular surgeons. When vascular surgeons started doing endovas-
cular procedures, we sort of jumped into it and really did not think
about the radiation. Our interventional radiology colleagues spend
a great deal of time and effort training in how to reduce the
radiation dose. Do the faculty and staff at the Cleveland Clinic
receive any training regarding how to limit the radiation dose
during these procedures?
p
oDr Greenberg. We have a set policy that requires anyone
ntending to use a fluoroscope to complete a fluoroscopic
raining module. It involves a PowerPoint presentation, and at
he end of it, they have to take a test and pass the test.
urthermore, anyone whose occupational exposure exceeds the
0% ALARA limit on a given year has to retake the test. Now,
hether or not that works, with respect to properly instructing
ndividuals and decreasing radiation dose, is the subject of some
oncern. We have never had an operator who actually has been
rohibited from operating because they have exceeded their
adiation dose. However, I do think that vascular surgeons as a
hole are not well educated on the risks and how we calculate
he potential differences between deterministic and stochastic
ffects of radiation, and it is something that we as a group
hould probably focus on more.
Dr Benjamin Starnes (Seattle, Wash). Radiation safety is
learly a hot topic today. My question mainly has to do with the
xposure of the operating room staff and/or the operating person-
el. Hybrid operating rooms have become increasingly popular
hese days and some have advocated that these hybrid operating
ooms do not need control rooms or radiation safety zones for the
perative staff. Are you are suggesting, based on your data that
ontrol rooms are not needed or, stated another way, a radiation-
afe zone is not needed in a hybrid operating room? Thank you for
our clarification.
Dr Panuccio. No. The hybrid room can help us to reduce
he amount of personnel that we need during the procedure.
ne operator can control the entire machine and that is better.
he goal is to always be more than 6 feet away from the imaging
ystem, and at that point, the amount of exposure is minimal.
owever, the protection adjuncts, such as lead shielding, skirt-
ng for the tables, thyroid collars, and whatnot are obviously
ritical to reduce scatter and personnel dose. These are all
ortable methods of reducing dose and can be used in any kind
f room with imaging equipment.
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Volume 53, Number 4 Panuccio et al 894.e1Table IV, online only. Effective dose estimation based on organ and tissue exposure directly measured in the phantom
model for two different radiation patterns (TAAA type 2 and 3 and for TAAA type 4)
Organ
Type 2 & 3 TAAA Type 4 TAAA
Weighting
tissue factora
Phantom
dose (mGy)
Phantom organ
ED (mSv)
Patient organ ED
(mSv) (mean)
Phantom
dose (mGy)
Phantom organ
ED (mSv)
Patient organ ED
(mSv) (mean)
Breast 0.12 24.6 3.0 2.97 9.2 1.10 0.71
Colon 0.12 164.0 19.7 19.79 360.8 43.30 27.79
Lung 0.12 85.4 10.2 10.31 32.8 3.94 2.53
RBM 0.12 88.9 10.7 10.73 104.4 12.53 8.04
Stomach 0.12 237.1 28.5 28.61 297.1 35.65 22.88
Gonads 0.08 14.1 1.1 1.13 33.6 2.69 1.73
Bladder 0.04 15.4 0.6 0.62 26.3 1.05 0.67
Esophagus 0.04 44.8 1.8 1.80 15.2 0.61 0.39
Liver 0.04 324.9 13.0 13.07 291.3 11.65 7.48
Thyroid 0.04 3.9 0.2 0.16 1.6 0.06 0.04
Bone 0.01 69.2 0.7 0.70 66.4 0.66 0.42
Brain 0.01 1.0 0.0 0.01 0.07 0.00 0.00
Salivary glands 0.01 1.7 0.0 0.02 0.9 0.01 0.01
Skin 0.01 141.1 1.4 1.42 74.9 0.75 0.48
Remainder 0.12 300.8 36.1 36.29 387.7 46.53 29.86
Mean total effective dose 126.90 127.61 160.52 103.01
Mean KAP Gy cm2 1000.27 1005.73 1001.22 642.51
Remainder
Adrenals 801.3 937.4
Gall bladder 175.7 236.4
Heart 53.8 28.1
Kidney 695.0 969.4
Oral mucosa 1.7 0.7
Pancreas 565.9 809.4
Prostate 9.6 9.8
Small intestine 236.4 394.9
Spleen 640.9 806.4
Thymus 27.8 3.7
Uterus 55.3 82.6
ET tissue 77.3 32.3
ED, Effective dose; ET, extra thoracic tissue;Gy,Gray;KAP, kerma area product;RBM, red bonemarrow; Sv, Sievert; TAAA, thoracoabdominal aortic aneurysm.
aIn the last column, the estimated mean value for a patient.
